Vikas Lifecare Limited (NSE: VIKASLIFE | BSE: 542655)

By Raveendran R | Updated on:

Source: Vikas Lifecare Limited Annual Report FY 2024-25 (Fiscal Year Ended March 31, 2025)

Metrics for FY 2024-25 Ended Mar 31, 2025
Profit & Loss (₹ Cr)
Revenue
₹480.02 Cr (▲ 7.7%)
Prev Year: ₹445.75 Cr
Gross Profit
₹15.03 Cr (▼ 43.3%)
Prev Year: ₹26.49 Cr
Operating Profit
₹4.36 Cr (▼ 85.7%)
Prev Year: ₹30.48 Cr
Net Profit
-₹10.92 Cr (▼ N/M)
Prev Year: ₹13.45 Cr
Ratios & Margins (% / x)
Gross Margin
3.13 % (▼ 281 bps)
Prev Year: 5.94 %
Operating Margin
0.91 % (▼ 593 bps)
Prev Year: 6.84 %
PAT Margin
-2.27 % (▼ 529 bps)
Prev Year: 3.02 %
ROCE
0.76 % (▼ 532 bps)
Prev Year: 6.08 %
ROE
-2.05 % (▼ 486 bps)
Prev Year: 2.81 %
ROA
-1.50 % (▼ 392 bps)
Prev Year: 2.42 %
Asset Turnover
0.66x (▼ 0.15 pts)
Prev Year: 0.80x
Balance Sheet (₹ Cr)
Total Assets
₹729.26 Cr (▲ 31.5%)
Prev Year: ₹554.70 Cr
Current Assets
₹270.03 Cr (▲ 12.9%)
Prev Year: ₹239.09 Cr
Total Liabilities
₹196.05 Cr (▲ 157.0%)
Prev Year: ₹76.27 Cr
Current Liabilities
₹152.68 Cr (▲ 185.8%)
Prev Year: ₹53.43 Cr
Total Debt
₹76.21 Cr (▲ 121.0%)
Prev Year: ₹34.49 Cr
Total Equity
₹533.21 Cr (▲ 11.4%)
Prev Year: ₹478.43 Cr
Working Capital
₹117.35 Cr (▼ 36.8%)
Prev Year: ₹185.66 Cr
Ratios & Margins (% / x)
Current Ratio
1.77x (▼ 2.71 pts)
Prev Year: 4.47x
Debt to Equity
0.14x (▲ 0.07 pts)
Prev Year: 0.07x
Debt to Assets
0.10x (▲ 0.04 pts)
Prev Year: 0.06x
Equity Multiplier
1.37x (▲ 0.21 pts)
Prev Year: 1.16x
Cash Flow (₹ Cr)
Operating Cash Flow
-₹222.20 Cr (▼ 432.2%)
Prev Year: -₹41.75 Cr
CapEx
₹12.70 Cr (▼ 20.5%)
Prev Year: ₹15.97 Cr
Free Cash Flow
-₹234.90 Cr (▼ 307.0%)
Prev Year: -₹57.72 Cr
Ratios & Margins (% / x)
FCF Margin
-48.94 % (▼ 3599 bps)
Prev Year: -12.95 %
Cash ROCE
-38.54 % (▼ 3021 bps)
Prev Year: -8.33 %
Cash ROE
-41.67 % (▼ 3295 bps)
Prev Year: -8.73 %
CF to Debt
-2.92x (▼ 1.71 pts)
Prev Year: -1.21x

📋 Quick Facts: Company Snapshot

Attribute Disclosed Detail
Official Company Name Vikas Lifecare Limited
Corporate Identity Number (CIN) L25111DL1995PLC073719
Stock Exchange Listing National Stock Exchange of India Ltd (NSE: VIKASLIFE) | BSE Limited (BSE: 542655)
Date of Incorporation November 9, 1995
Registered Office & Corporate Headquarters First Floor, Vikas House, 3, Arihant Nagar, Rohtak Road, Punjabi Bagh West, New Delhi – 110026, Delhi, India
Telephone & Official Contact +91-11-40450110 | info@vikaslifecarelimited.com / cs@vikaslifecarelimited.com
Managing Director Dr. Sundeep Kumar Dhawan (DIN: 09508137)
Chief Financial Officer (CFO) Dr. Chandan Kumar (DIN: 08139239)
Company Secretary & Compliance Officer Mr. Sanjay Kumar Jaiswal
Promoter & Major Shareholder Mr. Vikas Garg and Promoter Group (14.20% equity stake)
Industry / Business Sectors Polymer & Chemical Compounds, FMCG & Agro Commodities, Infrastructure Products, and Smart Metering Solutions
Manufacturing Facilities & Plants Factory I: Shahjahanpur, Dist. Alwar, Rajasthan | Factory II: Baikampady, Mangaluru, Karnataka | Rai Industrial Estate, Sonipat, Haryana (via Subsidiary)
Statutory Auditor M/s KSMC & Associates, Chartered Accountants (FRN: 003565N)
Secretarial Auditor M/s Avinash K & Co., Practicing Company Secretaries (COP: 18318)
Cost Auditor M/s Niraj Kumar Vishwakarma & Associates (Registration No: 003450)
Internal Auditor M/s G Mansi & Associates, Chartered Accountants (FRN: 035927N)
Registrar and Share Transfer Agent (RTA) Big Share Services Private Limited, Andheri (East), Mumbai – 400059

🏢 The Corporate Identity: Vikas Lifecare Overview, Promoters & History

The Big Picture: Business Model & Core Value Proposition

Vikas Lifecare Limited (VLL) is an ISO 9001:2015 certified diversified business corporation with an operating footprint spanning polymer compounding, specialty chemicals, agro-commodity trading, infrastructure inputs, and smart gas metering solutions. Historically incorporated as a specialty trading and manufacturing firm, the company operates across both business-to-business (B2B) and business-to-consumer (B2C) segments, developing engineered materials while simultaneously acting as a wholesale supplier and merchant exporter.

The company’s core value proposition rests on a multi-pronged industrial model. Within its chemical and compounding division, Vikas Lifecare specializes in up-cycling post-consumer and industrial plastic scrap into high-grade compounds, assisting institutional packaging manufacturers in discharging statutory Extended Producer Responsibility (EPR) mandates. Concurrently, the group has diversified aggressively into commercial agriculture and food commodity distribution, consumer beverages, and utility-scale smart metering infrastructure through domestic subsidiaries and joint ventures.

  • Diversified Operating Engine: Four dedicated business pillars encompassing Agro Commodities, Infrastructure Materials, Polymers & Specialty Additives, and Smart Utility Meters.
  • EPR & Circular Economy Pioneer: Specialized polymer processing units converting multi-layered plastic waste into injection-molded structural articles, tiles, and pallets.
  • Integrated Smart Infrastructure: Strategic 49:51 joint venture with Indraprastha Gas Limited (IGL) via subsidiary Genesis Gas Solutions to produce domestic and commercial smart gas meters.

The Founders, Promoters & Their Legacy

Vikas Lifecare Limited trace its operating roots back to the Vikas family enterprise, historically guided by promoter Mr. Vikas Garg. Under their stewardship, the enterprise scaled from a regional polymer distribution trading desk into a publicly traded conglomerate listed on both the National Stock Exchange of India (NSE) and BSE Limited. Mr. Vikas Garg holds an individual shareholding of 13.10% in the enterprise, while the overall Promoter & Promoter Group consolidates a 14.20% voting interest as of March 31, 2025.

Day-to-day managerial oversight and strategic execution are spearheaded by Managing Director Dr. Sundeep Kumar Dhawan, an esteemed scientist and former Emeritus Scientist at CSIR, who also serves as Chairman of the Solid Waste & Plastic Waste Management Group at the Central Pollution Control Board (CPCB). Dr. Dhawan’s scientific expertise in conducting polymers, energy storage, and waste-plastic upcycling anchors the company’s technical initiatives and product innovations.

The Journey: Corporate History & Key Milestones

Originally incorporated in November 1995, Vikas Lifecare Limited transitioned into an industrial compounding player through successive phases of organic capacity addition and strategic inorganic acquisitions:

  • 1995: Incorporation under the Companies Act, establishing trading lines in base polymers and chemical additives.
  • 2019: Direct listing of equity shares on the National Stock Exchange of India and BSE Limited on May 8, 2019, broadening public capital market participation.
  • 2019–2020: Commercialized specialized polymer compound manufacturing lines, including PE, PVC, Polypropylene (PP), and Thermoplastic Rubber (TPR) compounding.
  • 2021: Established the FMCG and Agro-Commodity business division, initiating domestic processing and wholesale trading of premium cashew nuts, pulses, and grain products.
  • 2022: Acquired a controlling 75% equity interest in Genesis Gas Solutions Private Limited (later raised to 95.36%), entering smart metering; acquired a 51.38% controlling stake in packaged beverage manufacturer Shashi Beriwal & Co. Private Limited.
  • 2023: Subsidiary Genesis Gas Solutions entered into a landmark joint venture agreement with Indraprastha Gas Limited to incorporate IGL Genesis Technologies Limited, establishing an integrated smart gas meter assembly facility.
  • 2024–2025: Department of Economy and Tourism (DET), Dubai, approved the incorporation of wholly owned overseas subsidiary Vikash Life Care Investment Management LLC; expanded agro operations and infrastructure product distribution across national utility frameworks.

The Corporate Umbrella & Group Structure

The corporate architecture of Vikas Lifecare Limited is structured across domestic operating subsidiaries, an offshore investment arm, and an associate joint venture:

  • Parent Operating Entity: Vikas Lifecare Limited (Standalone polymer manufacturing, agro trading, and infrastructure supply operations).
  • Genesis Gas Solutions Private Limited: 95.36% subsidiary dedicated to smart gas metering, smart water meters, and LoRa-enabled Meter Interface Units (MIUs).
  • Shashi Beriwal & Co. Private Limited: 51.38% subsidiary operating an FSSAI-licensed packaged beverage and fruit juice manufacturing facility in Rai, Sonipat, Haryana.
  • Vikash Life Care Investment Management LLC: 100.00% wholly owned subsidiary incorporated in Dubai, United Arab Emirates, formed to manage commercial investments and international trading enterprises.
  • IGL Genesis Technologies Limited: 49.00% step-down associate company incorporated in partnership with Indraprastha Gas Limited (51:49) for smart gas meter production.

⚙️ The Business Engine: Segments, Brands, Products & Operations

The Core Divisions & Segment Revenue Breakdown

Vikas Lifecare monitors operating performance through distinct product divisions under Ind AS 108. The Agro Products business dominates top-line contributions, followed by the expanding Infrastructure division, Polymer & Chemical trading/compounding, and Smart Gas Meter distribution.

Operating Segment Segment Revenue FY 2024-25 (₹ Cr) % Share of Total Revenue Segment Results / PBIT FY 2024-25 (₹ Cr) Segment Revenue FY 2023-24 (₹ Cr) Segment Results / PBIT FY 2023-24 (₹ Cr) Latest YoY (%)
Trading & Manufacturing – Agro 379.09 78.97% 10.92 375.55 12.44 +0.94%
Trading & Manufacturing – Infrastructure 80.35 16.74% 2.93 17.61 0.17 +356.27%
Trading & Manufacturing – Polymers 17.54 3.65% 0.33 26.42 2.08 -33.61%
Trading of Gas Meters & Services 3.05 0.64% 0.86 14.56 8.15 -79.05%
Real Estate Division 0.00 0.00% 0.00 5.06 3.67 -100.00%
Technical Consultancy Services 0.00 0.00% 0.00 6.55 0.00 -100.00%
Total Segment Revenue & Operating Results 480.02 100.00% 15.03 445.75 26.51 +7.69%

The operational data illustrates that while Agro Trading generated ₹379.09 Crores (78.97% of consolidated gross turnover), its operating profit stood at ₹10.92 Crores. The Infrastructure division exhibited rapid top-line growth, expanding over 350% from ₹17.61 Crores in FY 2023-24 to ₹80.35 Crores in FY 2024-25. Corporate overheads, unallocated expenses of ₹49.29 Crores, and finance costs of ₹4.57 Crores resulted in a consolidated Loss Before Tax of ₹12.87 Crores.

The Product & Service Catalog (with Operational KPIs & Order Book)

The enterprise provides a diverse catalog across its active operating domains:

  • Agro Products & Commodities: Wholesale processing, cleaning, sorting, and merchant trading of premium cashew nuts, raw dry fruits, basmati and non-basmati rice, and crystal sugar. The group operates an empanelment with NAFED (National Agricultural Cooperative Marketing Federation of India) and HOFED (U.P. Horticultural Co-Operative Marketing Federation).
  • Infrastructure Products: Sourcing and distribution of high-density polyethylene (HDPE) food-grade pipes, steel tubes, steel fittings, and MS rebar utilized extensively across rural piped water delivery schemes under the Central Government’s Jal Jeevan Mission.
  • Polymers, Recycled Compounds & Additives: Compounding of Virgin Polyethylene (PE), Polyvinyl Chloride (PVC), V-Blend Styrene-Ethylene-Butylene-Styrene (SEBS), Polypropylene (PP) granules, and Thermoplastic Rubber (TPR). Up-cycled compounds derived from post-consumer waste like EVA, PVC, and PP. Development of novel PBAT- and PLA-based biodegradable compostable resins.
  • Smart Metering & Distribution Solutions: Smart domestic diaphragm gas meters, ultrasonic gas meters for high-pressure city gas custody transfers, Meter Interface Units (MIUs), and automated LoRaWAN-integrated smart water meters.
  • Packaged Beverages: Through subsidiary Shashi Beriwal & Co., production of fruit juices, aerated flavored drinks (Cola, Orange, Mango, Jeera, Shikanji), and energy drinks in PET bottles, pouches, and tetra packs.

Under Ind AS 108 disclosures, revenue from a single customer within the Trading & Manufacturing – Agro division totaled ₹49.81 Crores during FY 2024-25 (representing approximately 10.38% of consolidated turnover), demonstrating noticeable counterparty concentration.

The Names You Know: Key Brands & Flagship Portfolio

Brand / Product Name Category / Business Segment Target Market & Key Positioning
V-Blend / VLL Compounds Polymer & Specialty Compounds Industrial footwear manufacturers, cable extruders, and molded goods processors
Vikas Premium Agro Agro Commodities (Rice, Cashew, Sugar) Domestic retail distributors, wholesale dry-fruit traders, institutional state cooperatives
Genesis Smart Gas Utility Gas Metering Systems City Gas Distribution (CGD) companies such as IGL, Gujarat Gas Limited, and domestic utilities
SBBPL Beverages Packaged Consumer Beverages Tier-II/III consumer markets across Northern India for accessible mass-market refreshments

Mapping the Domestic & Global Reach (India vs. Exports)

The group’s operational footprint is overwhelmingly domestic, though targeted international export dispatches are undertaken across selected agricultural corridors.

Geographic Market FY 2024-25 Revenue (₹ Cr) % Share of Total Revenue FY 2023-24 Revenue (₹ Cr) % Share of Total Revenue Latest YoY (%)
Domestic (India) 476.17 99.20% 443.98 99.60% +7.25%
Exports (International) 3.85 0.80% 1.76 0.40% +118.75%
Total Operating Revenue 480.02 100.00% 445.75 100.00% +7.69%

In FY 2024-25, international revenues totaled ₹3.85 Crores, dispatched wholly to Ghana. In the comparative FY 2023-24 period, export dispatches were recorded to China (₹1.40 Crores), Bangladesh (₹0.22 Crores), and Mauritius (₹0.14 Crores).

The Brick & Mortar Footprint: Manufacturing Plants, R&D & Offices

The company supports its operations via strategic fixed facilities across India:

  • Factory I (Rajasthan): Located at G-83, Vigyan Nagar, RIICO Industrial Area, Shahjahanpur, District Alwar, Rajasthan – 301706. Operates modern plastic compounding extruders, twin-screw compounding lines, and an integrated analytical testing laboratory.
  • Factory II (Karnataka): Situated at Plot No. 193, Revenue Survey No. 93, Baikampady, District Dakshina Kannada, Mangaluru, Karnataka – 575011. Dedicated to premium raw and processed cashew nut grading and packing.
  • Subsidiary Beverage Facility (Haryana): Shashi Beriwal & Co. operates an FSSAI-registered beverage processing plant at Rai Industrial Estate, Sonipat, Haryana, with an installed capacity of 50 Kilo Liters/day across PET, tetra pack, and pouch formats.
  • Joint Venture Metering Assembly (Noida/Delhi NCR): IGL Genesis Technologies Limited plant site setup with Holley Group (Hangzhou Beta Meter Co., Ltd) technical collaboration.
  • Corporate & Registered Office: Vikas House, 3, Arihant Nagar, Rohtak Road, Punjabi Bagh West, New Delhi – 110026.

📊 The Financial Health: The Numbers Simplified

Multi-Year Financial Highlights (₹ in Crores)

Financial Metric FY 2024-25 (Consolidated) FY 2023-24 (Consolidated) FY 2024-25 (Standalone) FY 2023-24 (Standalone) Latest YoY (%)
Revenue from Operations 480.02 445.75 463.58 416.72 +7.69%
Other Income 25.96 26.16 26.33 26.17 -0.76%
Total Income 505.99 471.90 489.90 442.89 +7.22%
Operating Profit (EBITDA before exceptionals) 4.36 30.48 6.88 28.79 -85.70%
Profit / (Loss) Before Tax (PBT) (12.87) 17.08 (3.55) 23.25 N/M
Profit / (Loss) After Tax (PAT) (10.92) 13.45 (2.26) 19.32 N/M
Total Equity (Net Worth) 533.21 478.43 544.97 481.54 +11.45%
Total Borrowings (Debt) 76.21 34.49 43.48 23.01 +120.96%
Total Assets 729.26 554.70 703.32 537.47 +31.47%

Earnings, Expenses, & Take-Home Profits (Consolidated Profit & Loss)

Consolidated turnover expanded by 7.69% to ₹480.02 Crores in FY 2024-25, supported by volume trading in agricultural commodities and structural steel infrastructure products. However, profitability deteriorated sharply, dropping from a net profit of ₹13.45 Crores in FY 2023-24 into a net loss of ₹10.92 Crores in FY 2024-25, primarily weighed down by significant fair value mark-to-market losses on quoted investment portfolios, increased finance costs, and losses incurred by the associate joint venture entity.

Particulars (Schedule III Statement of Profit and Loss) FY 2024-25 (₹ Cr) FY 2023-24 (₹ Cr) Latest YoY (%)
Revenue from Operations 480.02 445.75 +7.69%
Other Income 25.96 26.16 -0.76%
Total Income 505.99 471.90 +7.22%
Cost of Materials Consumed 17.10 15.35 +11.40%
Purchases of Stock-in-Trade 448.61 397.06 +12.98%
Changes in Inventories of Finished Goods, WIP and Stock-in-Trade (0.72) 6.85 N/M
Employee Benefits Expense 4.42 5.83 -24.19%
Finance Costs 4.57 2.87 +59.23%
Depreciation and Amortisation Expense 6.74 3.65 +84.66%
Other Expenses 32.22 16.33 +97.31%
Total Expenses 512.94 447.93 +14.51%
Profit / (Loss) Before Exceptional Items, Share of Associate & Tax (6.95) 23.97 N/M
Exceptional Items 0.00 6.39 -100.00%
Add: Share of Profit / (Loss) in Joint Venture / Associate Company (5.92) (0.50) +1084.00%
Profit / (Loss) Before Tax (12.87) 17.08 N/M
Current Tax 3.78 2.49 +51.81%
Deferred Tax (Credit) / Charge (5.93) 1.13 N/M
Prior Period Tax Adjustments 0.19 0.00 N/M
Total Tax Expense / (Credit) (1.95) 3.63 N/M
Profit / (Loss) for the Year (PAT) (10.92) 13.45 N/M
Net Profit / (Loss) Attributable to: Owners of the Parent (10.61) 14.03 N/M
Net Profit / (Loss) Attributable to: Non-Controlling Interest (0.30) (0.57) -47.37%
Total Other Comprehensive Income (Net of Tax) 3.78 (1.31) N/M
Total Comprehensive Income for the Year (7.13) 12.14 N/M
Basic Earnings Per Share (₹) -0.06 0.09 N/M
Diluted Earnings Per Share (₹) -0.04 0.08 N/M

The operational margin profile underscores that Vikas Lifecare runs a predominantly low-margin merchant distribution business model. In FY 2024-25, Purchases of Stock-in-Trade accounted for ₹448.61 Crores (93.46% of operational revenues). The substantial rise in Other Expenses to ₹32.22 Crores was accentuated by fair value losses on financial investments of ₹19.60 Crores, legal and professional disbursements of ₹4.25 Crores, and transport freight charges of ₹2.46 Crores.

Assets, Borrowings, & Net Worth (Consolidated Balance Sheet)

Total consolidated assets expanded by 31.47% from ₹554.70 Crores as on March 31, 2024, to ₹729.26 Crores as on March 31, 2025. This balance sheet expansion was primarily fueled by an advance of ₹280.94 Crores classified under Non-Current Financial Assets in relation to the Ebix Inc consortium transaction, counterbalanced by warrants conversion proceeds into equity and an increase in short- and long-term borrowing facilities.

Balance Sheet Items (Ind AS Consolidated) As at March 31, 2025 (₹ Cr) As at March 31, 2024 (₹ Cr) Latest YoY (%)
ASSETS
Non-Current Assets
Property, Plant and Equipment 35.86 30.30 +18.35%
Capital Work in Process 0.76% 6.08% –
Investment Property 7.15 7.26 -1.52%
Intangible Assets 6.87 7.81 -12.04%
Right of Use Assets 0.47 0.00 N/M
Goodwill 10.44 10.44 0.00%
Financial Assets: Non-Current Investments 53.96 182.70 -70.47%
Financial Assets: Non-Current Trade Receivables 2.93 0.17 +1623.53%
Financial Assets: Non-Current Loans 3.91 3.02 +29.47%
Financial Assets: Other Non-Current Financial Assets 283.42 3.47 +8067.72%
Deferred Tax Assets (Net) 4.50 0.00 N/M
Income Tax Assets (Net) 0.05 0.00 N/M
Other Non-Current Assets 49.02 70.37 -30.34%
Total Non-Current Assets 459.23 315.61 +45.51%
Current Assets
Inventories 4.80 9.21 -47.88%
Financial Assets: Current Trade Receivables 128.01 145.99 -12.32%
Financial Assets: Cash and Cash Equivalents 5.73 13.84 -58.60%
Financial Assets: Current Loans 0.11 1.66 -93.37%
Financial Assets: Other Current Financial Assets 37.44 17.48 +114.19%
Other Current Assets 90.66 47.13 +92.36%
Assets Held for Sale 3.28 3.78 -13.23%
Total Current Assets 270.03 239.09 +12.94%
TOTAL ASSETS 729.26 554.70 +31.47%
EQUITY AND LIABILITIES
Equity
Equity Share Capital 185.98 165.23 +12.56%
Other Equity 345.78 311.46 +11.02%
Equity Attributable to Shareholders of the Company 531.76 476.69 +11.55%
Non-Controlling Interests 1.44 1.74 -17.24%
Total Equity 533.21 478.43 +11.45%
Non-Current Liabilities
Financial Liabilities: Non-Current Borrowings 38.52 17.71 +117.50%
Financial Liabilities: Non-Current Lease Liabilities 0.30 0.00 N/M
Financial Liabilities: Other Financial Liabilities 0.20 0.19 +5.26%
Provisions (Non-Current) 0.45 0.38 +18.42%
Deferred Tax Liabilities (Net) 0.00 0.16 -100.00%
Other Non-Current Liabilities 3.90 4.40 -11.36%
Total Non-Current Liabilities 43.37 22.84 +89.89%
Current Liabilities
Financial Liabilities: Current Borrowings 37.70 16.78 +124.67%
Financial Liabilities: Current Lease Liabilities 0.18 0.00 N/M
Financial Liabilities: Trade Payables – MSME 1.04 2.75 -62.18%
Financial Liabilities: Trade Payables – Non-MSME 58.71 12.01 +388.84%
Financial Liabilities: Other Financial Liabilities 10.51 10.12 +3.85%
Provisions (Current) 0.03 0.03 0.00%
Other Current Liabilities 37.59 7.59 +395.26%
Current Tax Liabilities (Net) 6.91 4.15 +66.51%
Total Current Liabilities 152.68 53.43 +185.76%
Total Liabilities (Non-Current + Current) 196.05 76.27 +157.05%
TOTAL EQUITY AND LIABILITIES 729.26 554.70 +31.47%

Working capital analysis reveals meaningful shifts across operating components. Consolidated current assets of ₹270.03 Crores stand against current liabilities of ₹152.68 Crores, producing a Current Ratio of 1.77 as of March 31, 2025 (compared to 4.47 in the preceding year). On a standalone basis, the Company reported a Current Ratio of 2.40 versus 6.87 in FY 2023-24.

Based on consolidated revenues of ₹480.02 Crores, the enterprise closed the financial year with an Inventory Holding Period of approximately 4 days (₹4.80 Crores), reflecting minimal manufacturing inventory and brisk trading turnaround. Trade receivables of ₹128.01 Crores indicate an average collection cycle of approximately 97 days. In contrast, consolidated trade payables rose sharply to ₹59.75 Crores (comprising ₹1.04 Crores due to micro and small enterprises and ₹58.71 Crores due to other trade creditors), representing approximately 47 days of operating material purchases.

Cash Flow: Tracking the Money Movement

The Statement of Cash Flows shows substantial cash redeployment during the financial period under review. Operating activities generated a negative net cash flow of ₹222.20 Crores, largely as a consequence of working capital absorption via capital advances, arbitration-tied consortium outlays, and trade extensions.

Consolidated Cash Flow Activities FY 2024-25 (₹ Cr) FY 2023-24 (₹ Cr) Latest YoY (%)
Net Profit / (Loss) Before Tax (13.10) 23.97 N/M
Adjustments for Non-Cash / Investing Items 18.89 (20.38) N/M
Operating Profit Before Working Capital Changes 5.79 3.58 +61.73%
Changes in Working Capital: Inventories 4.42 3.32 +33.13%
Changes in Working Capital: Trade Receivables 16.63 26.90 -38.18%
Changes in Working Capital: Financial & Other Assets (324.30) (20.68) +1468.18%
Changes in Working Capital: Trade Payables & Other Liabilities 74.95 (53.04) N/M
Cash Generated from Operations (222.51) (39.92) +457.39%
Taxes Paid (Net) 0.31 (1.83) N/M
Net Cash Flow from Operating Activities (A) (222.20) (41.75) +432.22%
Purchase of Property, Plant and Equipment (CapEx) 12.70 15.97 -20.48%
Proceeds from Sale of Property, Plant and Equipment 0.76% 6.08% –
Acquisition / Realization of Investments & Advances (Net) 115.25 (82.89) N/M
Other Investing Inflows (Interest, Dividends, Rents, Forfeitures) 9.30 1.72 +440.70%
Net Cash Flow from / (Used in) Investing Activities (B) 106.29 (90.60) N/M
Proceeds / (Repayment) of Short-Term Borrowings 0.76% 6.08% –
Proceeds / (Repayment) of Non-Current Borrowings 0.76% 6.08% –
Proceeds from Share Warrants / Equity Issue (Net of Premium) 0.76% 6.08% –
Finance Costs Paid (4.38) (2.87) +52.61%
Net Cash Flow from / (Used in) Financing Activities (C) 107.80 136.57 -21.07%
Net Increase / (Decrease) in Cash and Cash Equivalents (A+B+C) (8.11) 4.22 N/M
Cash and Cash Equivalents at Beginning of the Year 13.84 9.61 +44.02%
Cash and Cash Equivalents at End of the Year 5.73 13.84 -58.60%

Funding the Future: CapEx, CWIP, R&D & Foreign Exchange

Capital expenditure additions to tangible property, plant, and equipment aggregated ₹11.55 Crores on a gross basis during the year, with total cash outflow on property acquisitions totaling ₹12.70 Crores. These additions encompassed expansion of warehouse infrastructure, compounding capacity enhancements at Shahjahanpur, and land parcel acquisitions.

Capital Work-in-Progress (CWIP) as of March 31, 2025, stood at ₹0.65 Crores (up from ₹0.07 Crores in FY 2023-24), representing ongoing residential and commercial construction activities at Bengali Market, New Delhi. Research and Development programs within the company remain focused on value-added sustainability projects:

  • Conversion of Rice Husk Ash into Nano-Silica: Utilizing agro-waste residues to synthesize precipitated silica fillers for high-performance elastomer compounding.
  • Multi-Layered Plastics (MLP) Upcycling: Commercialization of patented continuous extrusion techniques to convert post-consumer laminated packaging scraps into structural industrial pallets and outdoor interlocking pavers.
  • Intelligent Functional Polymers: Prototype development of smart self-healing industrial coatings and electromagnetic interference (EMI) shielding composite substrates.

Foreign exchange dynamics for the fiscal year reflected total export earnings of ₹3.85 Crores (dispatched to Ghana), while direct import outlays on materials and machinery components were monitored under customs authorizations.

👥 Power & Control: Corporate Governance, Leadership & Ownership

The Brain Trust: Board of Directors & Key Managerial Personnel (KMP)

The company maintains an optimum mix of executive and non-executive independent leadership on its Board of Directors in conformity with Regulation 17 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.

Name of Director / KMP Designation / Role DIN Category
Dr. Sundeep Kumar Dhawan Managing Director 09508137 Executive Director (Liable to Retire by Rotation)
Mr. Parag Dadeech Whole Time Director 08103407 Executive Director
Dr. Chandan Kumar Executive Director & CFO 08139239 Executive Director
Mr. Kamal Ghildiyal Executive Director (Commercial) 07706990 Executive Director (Appointed w.e.f. May 28, 2025)
Dr. Richa Sharma Non-Executive Independent Director 08709599 Non-Executive & Independent (Audit Committee Chair)
Mr. Anil Kumar Non-Executive Independent Director 07215544 Non-Executive & Independent
Dr. Samanta Yadav Non-Executive Independent Director 10690525 Non-Executive & Independent
CA Vijay Kumar Goel Non-Executive Independent Director 05014980 Non-Executive & Independent (Appointed August 14, 2025)
Mr. Sanjay Kumar Jaiswal Company Secretary & Compliance Officer KMP Key Managerial Personnel (Appointed May 17, 2024)

Who Owns the Stock? Shareholding Pattern

As of March 31, 2025, the issued and fully paid-up equity share capital of the company stood at ₹185.98 Crores divided into 1,85,76,68,560 equity shares of face value of Re. 1/- each. Public shareholding dominates the cap table, holding an 85.80% aggregate interest.

Shareholder Category Number of Shares Held % of Issued Equity Capital
Promoters & Promoter Group 26,38,13,968 14.20%
Resident Individuals 1,37,08,57,898 73.79%
Bodies Corporate 14,06,99,418 7.57%
Non-Resident Indians (NRIs) 4,83,07,422 2.60%
Hindu Undivided Families (HUF – Public) 2,44,72,467 1.32%
Foreign Portfolio Investors (FPIs) 85,36,797 0.46%
Clearing Members & Trusts 9,77,585 0.06%
Financial Institutions & Banks 3,005 0.00%
Total Equity Base 1,85,76,68,560 100.00%

Among prominent shareholders, promoter Mr. Vikas Garg holds 24,33,53,080 shares (representing 13.10% of total voting capital). The remaining promoter group holdings are dispersed across family members, including Vivek Garg (1.08%). The entire promoter holding is maintained in 100% dematerialized form.

🗺️ The Corporate Family Tree: Group Structure & Strategic Investments

Subsidiaries, Associates, & Joint Ventures (Form AOC-1)

Vikas Lifecare Limited accounts for two domestic operating subsidiaries, one offshore entity, and an equity-accounted joint venture associate under Section 129(3) read with Schedule III of the Companies Act, 2013.

Entity Name Relationship Country of Incorporation % Equity Holding Operating Turnover (₹ Cr) Profit / (Loss) After Tax (₹ Cr)
Genesis Gas Solutions Private Limited Subsidiary India 95.36% 3.05 (8.88)
Shashi Beriwal & Co. Private Limited Subsidiary India 51.38% 13.40 0.23
Vikash Life Care Investment Management LLC Wholly Owned Subsidiary United Arab Emirates 100.00% 0.00 (0.25)
IGL Genesis Technologies Limited Step-Down Associate / Joint Venture India 49.00% 0.00 (11.52)

Genesis Gas Solutions Private Limited reported operating revenues of ₹3.05 Crores and a net loss of ₹8.88 Crores, affected by contested supplier litigations and pre-operational joint venture ramp-up expenses. Packaged beverage manufacturer Shashi Beriwal & Co. generated revenues of ₹13.40 Crores, generating a modest net profit after tax of ₹0.23 Crores. Associate IGL Genesis Technologies Limited incurred a pre-operational startup loss, of which Vikas Lifecare’s 49% proportionate share stood at ₹(5.92) Crores.

Strategic Investments, Credit Facilities & Contingent Liabilities

The group holds non-current financial investments valued at ₹53.96 Crores as of March 31, 2025. This includes unquoted equity in associate IGL Genesis Technologies Limited (₹26.69 Crores net carrying value), unquoted equity in Benchmark News Lab Private Limited (₹15.00 Crores), and strategic quoted stakes in Vikas Ecotech Limited (₹0.90 Crores) and Lorenzini Apparels Limited (₹6.88 Crores).

The company maintains a total funded debt profile of ₹76.21 Crores, comprising secured vehicle and mortgage bank term loans of ₹15.50 Crores, unsecured inter-corporate deposits of ₹23.01 Crores, and short-term working capital borrowings of ₹37.70 Crores. Off-balance sheet commitments and litigations disclose significant legal exposures:

  • Ebix Inc Consortium Arbitration Outlay: Note 9 discloses an advance of ₹280.94 Crores ($32.827 million net outstanding) contributed towards a consortium led by Eraaya Lifespaces Limited to acquire Ebix Inc. Following defaults, Vikas Lifecare initiated formal arbitration under Section 21 of the Arbitration and Conciliation Act, 1996, to claim equity shares of Ebix International Holdings Limited (UK).
  • CGST Show Cause Order: The company received an adjudication order on January 28, 2025, from the Additional Commissioner CGST raising a tax demand of ₹18.25 Crores (excluding interest and penalties) alleging wrongful ITC availment from 2017-18 to 2021-22. The order has been contested in appeal, with ₹2.00 Crores deposited under protest.
  • Direct Tax Demands: Outstanding disputed income tax demands aggregating ₹8.62 Crores across AY 2016-17 through AY 2024-25 pending before appellate forums.
  • Insolvency Applications against Subsidiary: Section 7 IBC applications pending before NCLT Delhi against Genesis Gas Solutions filed by AP Securitas (₹9.45 Crores) and Anil Puri (₹3.03 Crores).

🎯 The Strategic Outlook: Competitive Moats, Risks & Future Growth Plans

Competitive Advantages & Economic Moats

Vikas Lifecare’s operational strengths center on regulatory integration, specialized technical leadership, and strategic institutional partnerships:

  • Technical Competency in Advanced Recycling: Guided by Dr. S.K. Dhawan, the company has developed proprietary processes to upcycle challenging multi-layered plastics (MLP), filing two process patents for converting waste film into high-durability tiles and pallets.
  • Empaneled Agricultural Reach: Direct empanelment with premier state agencies including NAFED and HOFED enables large-scale agro-commodity distribution and institutional procurement advantages.
  • Strategic Utility Alliance via IGL Joint Venture: Through its 49% partnership in IGL Genesis Technologies Limited, the group participates in India’s domestic smart gas metering rollout, backed by global production technology licensed from Holley Group (Hangzhou Beta Meter Co., Ltd).

What Could Go Wrong? Key Challenges & Business Risks

Several operational, structural, and legal headwinds require rigorous institutional monitoring:

  • Large Capital Exposure in Arbitration: An advance of ₹280.94 Crores is locked in dispute with Eraaya Lifespaces Limited regarding the Ebix Inc consortium transaction, currently subject to arbitration. Any adverse determination or delay in recovery could strain liquidity.
  • Operating Margin Compression: Gross revenues remain heavily weighted toward low-margin commodity agro distribution (accounting for 78.97% of sales), where raw commodity price volatility directly impacts operating spreads.
  • Regulatory & Indirect Tax Claims: Pending CGST adjudication demands of ₹18.25 Crores and ongoing Enforcement Directorate provisional attachments (₹0.06 Crores bank account attachment under PMLA) represent continuing legal uncertainties.

The Next Chapter: Growth, Order Pipeline & CapEx Initiatives

The company is transitioning toward higher-value industrial segments. Forward-looking operational plans target the commercialization of PBAT/PLA biodegradable polymer compounding lines to provide certified alternatives to single-use plastics across retail packaging and disposable tableware.

In the smart metering arena, the commissioning of the IGL Genesis assembly plant aims to localize ultrasonic and smart diaphragm gas meter production, targeting an order pipeline across India’s expanding City Gas Distribution networks. Simultaneously, the company plans to scale backward integration in agro-processing by expanding cashew processing lines in Mangaluru and evaluating grain milling facilities.

The Verdict: Strategic Outlook & Conclusion

Vikas Lifecare Limited exhibits the dual characteristics of a high-volume merchant trader and an emerging industrial innovator. While top-line scale has reached ₹480.02 Crores, FY 2024-25 profitability was constrained by mark-to-market financial asset adjustments and joint venture losses.

The long-term investment profile of the enterprise hinges on the operational execution of its IGL Genesis smart meter plant, recovery of disputed consortium advances, and expanding high-margin recycled compounds to reduce dependence on thin-margin agricultural trading.

Frequently Asked Questions (FAQs) About Vikas Lifecare

Q1: What are the primary business operations of Vikas Lifecare Limited?

Vikas Lifecare operates across four principal segments: Agro Products (wholesale trading and processing of cashew nuts, rice, and sugar), Infrastructure Products (HDPE piping and structural steel bars for drinking water schemes), Polymers & Chemicals (manufacturing specialized and upcycled plastic compounds), and Smart Products (smart gas meters and utility IoT systems via Genesis Gas Solutions).

Q2: What were the company’s financial results for FY 2024-25?

For the fiscal year ended March 31, 2025, Vikas Lifecare reported consolidated Revenue from Operations of ₹480.02 Crores, compared to ₹445.75 Crores in FY 2023-24. Consolidated Loss After Tax stood at ₹10.92 Crores, against a Net Profit of ₹13.45 Crores in the preceding fiscal year, largely impacted by fair value investment losses and unallocated legal overheads.

Q3: Who owns and manages Vikas Lifecare Limited?

The company was promoted by Mr. Vikas Garg, who holds a 13.10% individual stake, with the overall Promoter & Promoter Group holding 14.20% as of March 31, 2025. Executive management is led by Managing Director Dr. Sundeep Kumar Dhawan, Executive Director & CFO Dr. Chandan Kumar, and Whole Time Director Mr. Parag Dadeech.

Q4: Where are the company’s primary manufacturing units located?

The group operates a polymer compounding and recycling plant in Shahjahanpur, Alwar, Rajasthan, an agro-processing facility in Baikampady, Mangaluru, Karnataka, and a packaged beverage manufacturing unit in Rai, Sonipat, Haryana (via subsidiary Shashi Beriwal & Co.). It is also setting up a smart gas meter plant in Noida/NCR via its joint venture with Indraprastha Gas Limited.

Q5: What is the company’s current debt and net worth position?

As on March 31, 2025, Vikas Lifecare’s consolidated Total Equity (Net Worth) stood at ₹533.21 Crores. Total borrowings stood at ₹76.21 Crores (comprising ₹38.52 Crores of non-current debt and ₹37.70 Crores of current borrowings), resulting in a low Net Debt-to-Equity ratio of 0.13.

Note: Calculation of percentage share of total segment and geographic revenues has been performed on the disclosed financial statements.

Note: Financial ratios, margins, YoY growth percentages, and % revenue shares are calculated by IndianCompanies.in based on disclosed Ind AS financial statements.

Official Site: https://www.vikaslifecarelimited.com